Meta Fluoxetine Hydrochloride

• CAT Number: R012798
• CAS Number: 79088-29-2
• Molecular Formula: C17H19ClF3NO
• Molecular Weight: 345.79
• Purity: ≥95%
• Synonyms: N-Methyl-γ-[3-(trifluoromethyl)phenoxy]benzenepropanamine Hydrochloride; N-Methyl-3-phenyl-3-[(α,α,α-trifluoro-m-tolyl)oxy]propylamine Hydrochloride; USP Fluoxetine Related Compound A
• Storage: 4°C
• IUPAC Name: N-methyl-3-phenyl-3-[3-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride
• InChI: InChI=1S/C17H18F3NO.ClH/c1-21-11-10-16(13-6-3-2-4-7-13)22-15-9-5-8-14(12-15)17(18,19)20;/h2-9,12,16,21H,10-11H2,1H3;1H
• InChIKey: JCRCCLNIWABPIS-UHFFFAOYSA-N
• SMILES: CNCCC(C1=CC=CC=C1)OC2=CC=CC(=C2)C(F)(F)F.Cl

Meta Fluoxetine Hydrochloride(CAT: R012798) is a structural analog of fluoxetine, which is widely known as an antidepressant and the active ingredient in medications like Prozac. Fluoxetine functions as a selective serotonin reuptake inhibitor (SSRI), increasing serotonin levels in the brain to help regulate mood. Although “meta fluoxetine” refers to a specific structural modification, it may share similar properties with fluoxetine, potentially affecting serotonin reuptake in the brain. The modification could influence the compound’s pharmacological profile, including its potency, effectiveness, or side effects. Meta Fluoxetine Hydrochloride might be studied for its therapeutic potential or as a chemical tool for research in neuropharmacology